EUR 1.37
(0.59%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 6.13 Million EUR | -8.89% |
2022 | 6.73 Million EUR | -25.63% |
2021 | 9.05 Million EUR | 130.73% |
2020 | 3.92 Million EUR | -13.45% |
2019 | 4.53 Million EUR | 33.54% |
2018 | 3.39 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | 3.65 Million EUR | -20.12% |
2024 Q1 | 5.69 Million EUR | -7.2% |
2024 Q2 | 4.57 Million EUR | -19.7% |
2023 Q3 | 6.13 Million EUR | -12.72% |
2023 FY | 6.13 Million EUR | -8.89% |
2023 Q4 | 6.13 Million EUR | 0.0% |
2023 Q2 | 7.03 Million EUR | -83.98% |
2023 Q1 | 43.86 Million EUR | 551.36% |
2022 Q2 | 8.07 Million EUR | -87.18% |
2022 FY | 6.73 Million EUR | -25.63% |
2022 Q4 | 6.73 Million EUR | 0.0% |
2022 Q3 | 6.73 Million EUR | -16.56% |
2022 Q1 | 62.97 Million EUR | 595.42% |
2021 Q4 | 9.05 Million EUR | 0.0% |
2021 Q1 | 1.78 Million EUR | -54.55% |
2021 FY | 9.05 Million EUR | 130.73% |
2021 Q2 | 6.81 Million EUR | 282.17% |
2021 Q3 | 9.05 Million EUR | 32.82% |
2020 FY | 3.92 Million EUR | -13.45% |
2020 Q4 | 3.92 Million EUR | 0.0% |
2019 FY | 4.53 Million EUR | 33.54% |
2018 FY | 3.39 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | 3.53 Million EUR | -73.628% |
Nexstim Plc | 2.98 Million EUR | -105.83% |
Revenio Group Oyj | -2.8 Million EUR | 319.143% |